A NOVEL APPROACH TO EVALUATE THE HOLISTIC CLINICAL UTILITY OF ENTERAL GLUTAMINE SUPPLEMENTATION ON MORBIDITY AND MORTALITY IN MAJOR BURNS

Main Article Content

Dr. Vijaykumar N, M.Ch.
Dr. Chandrashekar M S, M.Ch.
Dr. Mohan G Kakola
Dr. Saikumar P., M.S., (M.Ch.)

Keywords

glutamine, burns, burn mortality, enteral glutamine, antioxidants, burns nutrition, burn morbidity, SOFA score, delta sofa, severe burns

Abstract

Introduction- Glutamine plays a vital defensive role in the body during events of acute severe stress including burns, and affects the immune response, inflammatory pathway and catabolic responses.Thus, the effects of glutamine on body defenses is multifold, anddefiningthe criteria for a comprehensive look at the clinical benefit of glutamine supplementation in such cases can be troublesome.In this study, we compare serial sequential organ failure assessment (SOFA) scores, C-reactive protein (CRP) levels and mid-arm circumference (MAC) of burn patients in an attempt to assess the benefit of enteral glutamine supplementation in a holistic sense.


Materials And Methods- The studyincluded60 patients with more than 30% TBSA burns at admission and ages between 18 and 60 years. The subjectswere randomly allocated to two groups of 30 subjects each. The control group received standard nutritional supplementation, and the test group received an additional 0.3g/kg/day of enteral glutamine supplement. SOFA scores were assessed at admission and on day 4, and deltaSOFA (4-0) were calculated. CRP levels were assessed at day 4, 7 and 10 and MAC was measured at admission and at day 10. Results were tabulated and compared statistically.


Results-The average age among the test and control group were 33.50 +/- 12.01 years and 34.47 +/- 11.99 years respectively, with the average percentage of burns in the former and latter groups as 45.87 +/- 15.03 % TBSA and 45.73 +/- 12.99 % TBSA respectively. The deltaSOFA (4-0) among the two groups were 0.04 +/- 1.07 and 1.17 +/- 2.05, with a statistically significant reduction noted (p-value of 0.0444) in the glutamine group. There was a significant reduction (p 0.0173 = 0.0107) in CRP levels at day 10 among the groups, whereas the differences in values at day 4 and 7 were found to be insignificant. The difference in MAC (10-0) was also found to be significant (p = 0.0173).


Conclusion- Prophylactic enteral glutamine supplementation appears to confer protection against immune dysregulation, multi-organ dysfunction and hypercatabolic response in major burns, thereby reducing the overall morbidity and mortality in adult burn population.

Abstract 31 | PDF Downloads 19

References

1. Blomqvist BI, Hammarqvist F, von der Decken A, et al. Glutamine And alpha-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total Hip replacement. Metabolism 1995; 44: 1215–1222.
2. Zhou YP, Jiang ZM, Sun YH, et al. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled Clinical trial. JPEN J Parenter Enteral Nutr 2003; 27(4): 241–245
3. Planas M, Schwartz S, Arbos MA, et al. Plasma glutamine levels In septic patients. JPEN J Parenter Enteral Nutr 1993; 17: 299–300.
4. Kim M and Wischmeyer PE. Glutamine. World Rev Nutr Diet 2013; 105: 90–96.
5. Fan J, Wu J, Wu LD, et al. Effect of parenteral glutamine supplementation combined with enteral nutrition on Hsp90 Expression and lymphoid organ apoptosis in severely burned Rats. Burns 2016; 42: 1494–1506.
6. Garrel D, Patenaude J, Nedelec B, et al. Decreased mortality And infectious morbidity in adult burn patients given enteral Glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 2003; 31: 2444–2449.
7. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized Trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 368(16): 1487–1495
8. Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut Barrier function, and failure. J Burn Care Rehabil 2005;26:383–91.
9. Rose JK, Herndon DN (1997) Advances in the treatment of Burn patients. Burns 23:S19–S26
10. Lorente JA, Vallejo A, Galeiras R, Tómicic V, Zamora J, Cerdá E, de la Cal MA, Esteban A. Organ dysfunction as estimated by the sequential organ failure assessment score is related to outcome in critically ill burn patients. Shock 2009 Feb;31(2):125-31.
11. Calles J, Cohen B, Forme N, Guendil Z, Fermier B, Chassier C et al. Variation of the SOFA score and mortality in patients with severe burns: A cohort study. Burns 2023;49(1): 34-41.
12. Das A, Saimala G, Reddy N, Mishra P, Giri R, Kumar A et al. Mid-upper arm circumference as a substitute of the body mass index for assessment of nutritional status among adult and adolescent females: learning from an impoverished Indian state. Public health 2020 Feb; !&(: 68-75.